BENGALURU, INDIA , NOV. 3, 2025 /PRNEWSWIRE/ -- INFOSYS (NSE: INFY) (BSE: INFY) (NYSE: INFY), A GLOBAL LEADER IN NEXT-GENERATION DIGITAL SERVICES AND CONSULTING, TODAY ANNOUNCED THE LAUNCH OF INFOSYS TOPAZ FABRIC. THIS IS A STACK OF LAYERED, COMPOSABLE, OPEN AND INTEROPERABLE DATA INFRASTRUCTURE, MODELS, AGENTS, FLOWS, AND AI APPS THAT HELP UNIFY AND ACCELERATE IT SERVICE DELIVERY ACROSS THE ENTERPRISE LANDSCAPE.
INFY
• Nov. 3, 2025
WILMINGTON, DEL., NOV. 03, 2025 (GLOBE NEWSWIRE) -- INTERDIGITAL, INC. (NASDAQ: IDCC), A MOBILE, VIDEO AND AI TECHNOLOGY RESEARCH AND DEVELOPMENT COMPANY, TODAY ANNOUNCED IT HAS BEEN AWARDED AN INJUNCTION AGAINST DISNEY BY A COURT IN GERMANY.
IDCC
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM, A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, ANNOUNCES THAT IT IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF STRIDE, INC. ("STRIDE" OR "THE COMPANY") (NYSE: LRN) FOR VIOLATIONS OF THE SECURITIES LAWS. THE INVESTIGATION FOCUSES ON WHETHER THE COMPANY ISSUED FALSE AND/OR MISLEADING STATEMENTS AND/OR FAILED TO DISCLOSE INFORMATION PERTINENT TO INVESTORS.
LRN
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP ANNOUNCES THAT IT IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF STRIDE, INC. ("STRIDE" OR "THE COMPANY") (NYSE: LRN) FOR VIOLATIONS OF THE SECURITIES LAWS. INVESTIGATION DETAILS: THE INVESTIGATION FOCUSES ON WHETHER THE COMPANY ISSUED MISLEADING STATEMENTS AND/OR FAILED TO DISCLOSE INFORMATION PERTINENT TO INVESTORS.
LRN
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST WPP PLC ("WPP" OR "THE COMPANY") (NYSE: WPP ) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. SHAREHOLDERS WHO PURCHASED SHARES OF WPP DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENTS.
WPP
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST MOLINA HEALTHCARE, INC. ("MOLINA" OR "THE COMPANY") (NYSE: MOH) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN FEBRUARY 5, 2025 AND JULY 23, 2025, INCLUSIVE (THE "CLASS PERIOD"), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE DECEMBER 2, 2025.
MOH
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST MOLINA HEALTHCARE, INC. ("MOLINA " OR "THE COMPANY") (NYSE: MOH ) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. SHAREHOLDERS WHO PURCHASED SHARES OF MOH DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENTS.
MOH
• Nov. 3, 2025
LONDON--(BUSINESS WIRE)--HOULIHAN LOKEY, INC. (NYSE:HLI), THE GLOBAL INVESTMENT BANK, ANNOUNCED TODAY THAT MARCO VOCI HAS JOINED THE FIRM AS A MANAGING DIRECTOR IN THE GLOBAL CONSUMER GROUP. BASED IN LONDON, MR. VOCI WILL FOCUS ON THE ACTIVE LIFESTYLE, BRANDED CONSUMER PRODUCTS, AND LUXURY GOODS SECTORS ACROSS EUROPE, THE MIDDLE EAST, AND AFRICA (EMEA). HE WILL WORK CLOSELY WITH ALEXANDER GRÜNWALD, MANAGING DIRECTOR AND GLOBAL CO-HEAD OF THE CONSUMER GROUP, WHO LEADS THE FIRM'S LUXURY GOODS TEA.
HIRRF
• Nov. 3, 2025
PRESS RELEASE
AEXAY
• Nov. 3, 2025
NEW YORK, NOV. 03, 2025 (GLOBE NEWSWIRE) -- VERIZON COMMUNICATIONS INC. (“VERIZON”) (NYSE, NASDAQ: VZ) TODAY ANNOUNCED THAT IT WILL REDEEM THE FOLLOWING NOTES ON DECEMBER 16, 2025 (THE “REDEMPTION DATE”):
VZ
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST V.F. CORPORATION ("VF " OR "THE COMPANY") (NYSE: VFC ) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION.
VFC
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP REMINDS INVESTORS THAT IT IS INVESTIGATING CLAIMS AGAINST FLUOR CORPORATION ("FLUOR" OR "THE COMPANY") (NYSE: FLR) FOR VIOLATIONS OF SECURITIES LAWS. THE INVESTIGATION CENTERS ON WHETHER THE COMPANY MADE FALSE AND/OR MISLEADING STATEMENTS OR OMITTED INFORMATION CRITICAL TO INVESTORS.
FLR
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST QUANTUM CORPORATION ("QUANTUM " OR "THE COMPANY") (NASDAQ: QMCO ) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. SHAREHOLDERS WHO PURCHASED SHARES OF QMCO DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENTS.
QMCO
• Nov. 3, 2025
STOCKHOLM, 3. NOVEMBER 2025 - VIRTUNE GAB HEUTE BEKANNT, DASS DIE MONATLICHE NEUGEWICHTUNG DES VIRTUNE CRYPTO ALTCOIN INDEX ETPS ABGESCHLOSSEN WURDE. DAS PRODUKT IST AN DER DEUTSCHEN BÖRSE XETRA, NASDAQ STOCKHOLM UND NASDAQ HELSINKI NOTIERT (ISIN: SE0023260716). NEBEN DEM VIRTUNE CRYPTO ALTCOIN INDEX ETP UMFASST DAS PRODUKTPORTFOLIO VON VIRTUNE FOLGENDE PRODUKTE:VIRTUNE BITCOIN ETPVIRTUNE STAKED ETHEREUM ETPVIRTUNE STELLAR ETPVIRTUNE STAKED SOLANA ETPVIRTUNE STAKED POLKADOT ETPVIRTUNE XRP ETPVIRTUNE AVALANCHE ETPVIRTUNE LITECOIN ETPVIRTUNE CHAINLINK ETPVIRTUNE ARBITRUM ETPVIRTUNE POLYGON ETPVIRTUNE STAKED CARDANO ETPVIRTUNE CRYPTO TOP 10 INDEX ETP SEKVIRTUNE CRYPTO TOP 10 INDEX ETP EURVIRTUNE BITCOIN PRIME ETPVIRTUNE COINBASE 50 INDEX ETPVIRTUNE STAKED NEAR ETPVIRTUNE SUI ETP INDEXZUSAMMENSETZUNG PER 30.
• Nov. 3, 2025
STOCKHOLM, 3RD OF NOVEMBER 2025 - VIRTUNE AB (PUBL) ("VIRTUNE") TODAY ANNOUNCES THAT IT HAS COMPLETED THE MONTHLY REBALANCING OF THE VIRTUNE CRYPTO ALTCOIN INDEX ETP, LISTED ON NASDAQ STOCKHOLM, NASDAQ HELSINKI AND XETRA (ISIN CODE SE0023260716). IN ADDITION TO THE VIRTUNE CRYPTO ALTCOIN INDEX ETP, VIRTUNE'S PRODUCT PORTFOLIO INCLUDES: VIRTUNE BITCOIN ETPVIRTUNE STAKED ETHEREUM ETPVIRTUNE STELLAR ETPVIRTUNE STAKED SOLANA ETPVIRTUNE STAKED POLKADOT ETPVIRTUNE XRP ETPVIRTUNE AVALANCHE ETPVIRTUNE LITECOIN ETPVIRTUNE CHAINLINK ETPVIRTUNE ARBITRUM ETPVIRTUNE POLYGON ETPVIRTUNE STAKED CARDANO ETPVIRTUNE CRYPTO TOP 10 INDEX ETP SEKVIRTUNE CRYPTO TOP 10 INDEX ETP EURVIRTUNE BITCOIN PRIME ETPVIRTUNE COINBASE 50 INDEX ETPVIRTUNE STAKED NEAR ETP VIRTUNE SUI ETP INDEX ALLOCATION AS OF 30TH OCTOBER (BEFORE REBALANCING):BITCOIN CASH: 12.
• Nov. 3, 2025
STOCKHOLM, 3 NOVEMBER 2025 - VIRTUNE MEDDELAR IDAG ATT MAN HAR SLUTFÖRT DEN MÅNATLIGA REBALANSERINGEN AV VIRTUNE CRYPTO ALTCOIN INDEX ETP, NOTERAD PÅ NASDAQ STOCKHOLM, NASDAQ HELSINKI OCH XETRA (ISIN-KOD SE0023260716). UTÖVER VIRTUNE CRYPTO ALTCOIN INDEX ETP OMFATTAR VIRTUNES PRODUKTPORTFÖLJ FÖLJANDE PRODUKTER: VIRTUNE BITCOIN ETPVIRTUNE STAKED ETHEREUM ETPVIRTUNE STELLAR ETPVIRTUNE STAKED SOLANA ETPVIRTUNE STAKED POLKADOT ETPVIRTUNE XRP ETPVIRTUNE AVALANCHE ETPVIRTUNE LITECOIN ETPVIRTUNE CHAINLINK ETPVIRTUNE ARBITRUM ETPVIRTUNE POLYGON ETPVIRTUNE STAKED CARDANO ETPVIRTUNE CRYPTO TOP 10 INDEX ETP SEKVIRTUNE CRYPTO TOP 10 INDEX ETP EURVIRTUNE BITCOIN PRIME ETPVIRTUNE COINBASE 50 INDEX ETPVIRTUNE STAKED NEAR ETPVIRTUNE SUI ETP INDEXFÖRDELNING PER DEN 30 OKTOBER (FÖRE REBALANSERING):BITCOIN CASH: 12,24%XRP: 11,22%LITECOIN: 10,92%STELLAR: 10,56%SOLANA: 10,55%CHAINLINK: 9,96%CARDANO: 9,27%POLKADOT: 9,05%UNISWAP: 8,69%AVALANCHE: 7,54% INDEXFÖRDELNING PER DEN 31 OKTOBER (EFTER REBALANSERING):SOLANA: 10%XRP: 10%CARDANO: 10%AVALANCHE: 10%CHAINLINK: 10%LITECOIN: 10%STELLAR: 10%UNISWAP: 10% BITCOIN CASH 10%POLKADOT 10% I SAMBAND MED MÅNADENS REBALANSERING SKER DET INGA FÖRÄNDRINGAR I DE KRYPTOTILLGÅNGAR SOM IDAG FINNS I INDEXET.
• Nov. 3, 2025
ALM. BRAND A/S SHARE BUY-BACK PROGRAM TRANSACTIONS DURING 27 OCTOBER 2025 – 31 OCTOBER 2025 ON 5 MARCH 2025, ALM. BRAND A/S ANNOUNCED A SHARE BUY-BACK PROGRAM OF UP TO DKK 835.2 MILLION, AS DESCRIBED IN COMPANY ANNOUNCEMENT NO.
ABDBY
• Nov. 3, 2025
AUSTIN, NOV. 03, 2025 (GLOBE NEWSWIRE) -- THE ACCOUNTING SOFTWARE MARKET SIZE WAS VALUED AT USD 15. 23 BILLION IN 2025E AND IS EXPECTED TO REACH USD 29. 38 BILLION BY 2033 AND GROW AT A CAGR OF 8. 60% OVER 2026-2033.
• Nov. 3, 2025
HEALWELL HAS DIVESTED ITS POLYCLINIC FAMILY MEDICINE AND SPECIALTY GROUP OF CLINICS TO WELL HEALTH CLINIC NETWORK INC. ("WELL CLINICS"), WHO HAS BEEN PREVIOUSLY MANAGING THESE CLINICS FOR HEALWELL SINCE JANUARY 2024. HEALWELL HAS SOLD ITS INTEREST IN MUTUO HEALTH SOLUTIONS INC. ("MUTUO") TO WELLSTAR TECHNOLOGIES CORP. ("WELLSTAR"), SO IT CAN BETTER FOCUS ON ITS LARGE ENTERPRISE HEALTHCARE SOFTWARE AND AI BUSINESS.
HWAIF
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP ANNOUNCES THAT IT IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS OF ATYR PHARMA, INC. ("ATYR" OR "THE COMPANY") (NASDAQ: ATYR) FOR VIOLATIONS OF THE SECURITIES LAWS. INVESTIGATION DETAILS: THE INVESTIGATION FOCUSES ON WHETHER THE COMPANY ISSUED MISLEADING STATEMENTS AND/OR FAILED TO DISCLOSE INFORMATION PERTINENT TO INVESTORS.
ATYR
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST CYTOKINETICS, INCORPORATED ("CYTOKINETICS" OR "THE COMPANY") (NASDAQ: CYTK) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN DECEMBER 27, 2023 AND MAY 6, 2025, INCLUSIVE (THE "CLASS PERIOD"), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE NOVEMBER 17, 2025.
CYTK
• Nov. 3, 2025
AUSTIN, TEXAS--(BUSINESS WIRE)--FAL.CON EUROPE 2025, BARCELONA-- CROWDSTRIKE (NASDAQ: CRWD) TODAY RELEASED THE 2025 EUROPEAN THREAT LANDSCAPE REPORT, REVEALING THAT EUROPEAN ORGANIZATIONS ACCOUNTED FOR NEARLY 22% OF GLOBAL RANSOMWARE AND EXTORTION VICTIMS — SECOND ONLY TO NORTH AMERICA. RANSOMWARE OPERATIONS ARE MOVING FASTER THAN EVER, WITH CROWDSTRIKE OBSERVING ADVERSARY GROUPS LIKE SCATTERED SPIDER INCREASING RANSOMWARE DEPLOYMENT SPEED BY 48%, WITH THE AVERAGE ATTACK NOW TAKING JUST 24 HOUR.
CRWD
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST FLUOR CORPORATION ("FLUOR" OR "THE COMPANY") (NYSE: FLR) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN FEBRUARY 18, 2025 AND JULY 31, 2025, INCLUSIVE (THE "CLASS PERIOD"), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE NOVEMBER 14, 2025.
FLR
• Nov. 3, 2025
VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - NOVEMBER 3, 2025) - HYPER BIT TECHNOLOGIES LTD. (CSE: HYPE) (OTCID: HYPAF) (FSE: N7S0) (THE "COMPANY" OR "HYPER BIT") ANNOUNCES IT HAS BEEN NOTIFIED BY DOGECOIN MINING TECHNOLOGIES CORP. ("DMTC") THAT THE COMMENCEMENT OF MINING OF DOGECOIN AND LITECOIN BEGAN IN SEPTEMBER 2025 AND THE INITIAL 20 ELPHAPEX DG1+ MINERS, WHICH WERE ORDERED BY DMTC, ARE ONLINE AND HASHING AT THE 11MW, PURPOSE BUILT CRYPTO MINING DATACENTER CO-LOCATION FACILITY IN QUEBEC, CANADA.
LTC
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST LANTHEUS HOLDINGS, INC. ("LANTHEUS " OR "THE COMPANY") (NASDAQ: LNTH ) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. SHAREHOLDERS WHO PURCHASED SHARES OF LNTH DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENTS.
LNTH
• Nov. 3, 2025
GALASHIELS, SCOTLAND & MARLOW, ENGLAND--(BUSINESS WIRE)--KYOWA KIRIN INTERNATIONAL (“KKI”), A GROUP COMPANY OF KYOWA KIRIN CO., LTD. (TSE:4151, “KYOWA KIRIN”), A JAPAN-BASED GLOBAL SPECIALTY PHARMACEUTICAL COMPANY, TODAY ANNOUNCED THE APPOINTMENT OF JULIE DEHAENE-PUYPE AS PRESIDENT FOR THE REGION, EFFECTIVE 1 NOVEMBER 2025. JULIE FOLLOWS THE TENURE OF JEREMY MORGAN, WHO HAS SERVED AS PRESIDENT FOR THE INTERNATIONAL REGION SINCE 2023. MORGAN WILL SERVE IN AN ADVISOR ROLE TO THE BUSINESS THROUGH.
KYKOF
• Nov. 3, 2025
PRESS RELEASENOKIA AND ONELAYER PARTNER TO ACCELERATE SECURE PRIVATE 5G/LTE ADOPTION FOR UTILITIES NOKIA'S SECURE MISSION-CRITICAL PRIVATE NETWORKS COMBINED WITH ONELAYER'S OT ASSET VISIBILITY AND PROTECTION HELP UTILITIES MODERNIZE GRIDS WITH SECURE 5G/LTE. 3 NOVEMBER 2025ESPOO, FINLAND – NOKIA AND ONELAYER ARE COMBINING NOKIA'S SECURE MISSION-CRITICAL PRIVATE NETWORKS WITH ONELAYER'S OT ASSET MANAGEMENT TO HELP UTILITIES MODERNIZE GRIDS WITH SECURE 5G/LTE, ENABLING DEEPER DEVICE VISIBILITY, IMPROVED OPERATIONAL EFFICIENCY, AND STRONGER SECURITY ACROSS PRIVATE CELLULAR NETWORKS IN THE GROWING 5G/LTE MARKET.
NOK
• Nov. 3, 2025
HOUSTON, TX, NOV. 03, 2025 (GLOBE NEWSWIRE) -- THE WORLD SERVICES GROUP (WSG) EMPLOYMENT AND LABOR GROUP PROUDLY ANNOUNCES THE RELEASE OF ITS LATEST REPORT, "MANAGEMENT CONTRACTS: NEW TRENDS AND REGULATIONS. " DEVELOPED THROUGH COLLABORATION AMONG LEADING WSG MEMBER FIRMS ACROSS 22 JURISDICTIONS, THIS COMPREHENSIVE PUBLICATION UNITES EUROPE'S TOP LEGAL EXPERTS TO EXPLORE HOW EVOLVING CORPORATE GOVERNANCE STANDARDS ARE RESHAPING THE ROLE, RESPONSIBILITIES, AND ACCOUNTABILITY OF COMPANY DIRECTORS.
• Nov. 3, 2025
SEASONED EXECUTIVES BRING 40+ YEARS OF COMBINED LEADERSHIP ACROSS FINANCE AND GO-TO-MARKET FUNCTIONS AND ENTERPRISE SOFTWARE TECHNOLOGY COMPANIES. APPOINTMENTS ADVANCE DARKTRACE'S STRATEGY TO DEEPEN CUSTOMER VALUE, SCALE ITS GLOBAL OPERATIONS, AND DELIVER SUSTAINABLE GROWTH. SEASONED EXECUTIVES BRING 40+ YEARS OF COMBINED LEADERSHIP ACROSS FINANCE AND GO-TO-MARKET FUNCTIONS AND ENTERPRISE SOFTWARE TECHNOLOGY COMPANIES. APPOINTMENTS ADVANCE DARKTRACE'S STRATEGY TO DEEPEN CUSTOMER VALUE, SCALE ITS GLOBAL OPERATIONS, AND DELIVER SUSTAINABLE GROWTH.
DRKTF
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST SAVARA INC. ("SAVARA " OR "THE COMPANY") (NASDAQ: SVRA ) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. SHAREHOLDERS WHO PURCHASED SHARES OF SVRA DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENTS.
SVRA
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST FLY-E GROUP, INC. ("FLY-E " OR "THE COMPANY") (NASDAQ: FLYE ) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. SHAREHOLDERS WHO PURCHASED SHARES OF FLYE DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENTS.
FLYE
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST SAVARA INC. ("SAVARA" OR "THE COMPANY") (NASDAQ: SVRA) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN MARCH 7, 2024, AND MAY 23, 2025, INCLUSIVE (THE "CLASS PERIOD"), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE NOVEMBER 10, 2025.
SVRA
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST TRONOX HOLDINGS PLC ("TRONOX" OR "THE COMPANY") (NYSE: TROX) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN FEBRUARY 12, 2025 AND JULY 30, 2025, INCLUSIVE (THE "CLASS PERIOD"), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE NOVEMBER 3, 2025.
TROX
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST JAMES HARDIE INDUSTRIES PLC ("JAMES HARDIE" OR "THE COMPANY") (NYSE: JHX) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN MAY 20, 2025, AND AUGUST 18, 2025, INCLUSIVE (THE "CLASS PERIOD"), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE DECEMBER 23, 2025.
JHX
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST AVANTOR, INC. ("AVANTOR " OR "THE COMPANY") (NYSE: AVTR ) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. SHAREHOLDERS WHO PURCHASED SHARES OF AVTR DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENTS.
AVTR
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST JAMES HARDIE INDUSTRIES PLC ("JAMES HARDIE " OR "THE COMPANY") (NYSE: JHX ) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. SHAREHOLDERS WHO PURCHASED SHARES OF JHX DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENTS.
JHX
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST QUANTUM CORPORATION ("QUANTUM" OR "THE COMPANY") (NASDAQ: QMCO) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN NOVEMBER 15, 2024, AND AUGUST 18, 2025, INCLUSIVE (THE "CLASS PERIOD"), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE NOVEMBER 3, 2025.
QMCO
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST DEXCOM, INC. ("DEXCOM" OR "THE COMPANY") (NASDAQ: DXCM) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN JANUARY 8, 2024 AND JULY 25, 2024, INCLUSIVE (THE "CLASS PERIOD"), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE OCTOBER 21, 2024.
DXCM
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST AVANTOR, INC. ("AVANTOR" OR "THE COMPANY") (NYSE: AVTR) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN MARCH 5, 2024, AND OCTOBER 28, 2025, INCLUSIVE (THE "CLASS PERIOD"), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE DECEMBER 29, 2025.
AVTR
• Nov. 3, 2025
GARFIELD PROJECT - PRECIOUS METAL EXPLORATION UPDATE LONDON, UK / ACCESS NEWSWIRE / NOVEMBER 3, 2025 / GUARDIAN METAL RESOURCES PLC ('GUARDIAN METAL' OR THE 'COMPANY')(LON:GMET)(OTCQB:GMTLF), A STRATEGIC MINERAL EXPLORATION AND DEVELOPMENT COMPANY FOCUSED ON TUNGSTEN IN NEVADA, U.S., IS PLEASED TO PROVIDE AN UPDATE FOR THE COMPANY'S GARFIELD GOLD-SILVER-COPPER PROJECT ("GARFIELD" OR THE "PROJECT") LOCATED IN THE WALKER LANE MINERAL BELT, NEVADA. GUARDIAN METAL'S MISSION IS TO ESTABLISH ITS CO-FLAGSHIP PROJECTS, TEMPIUTE AND PILOT MOUNTAIN, AS THE CORNERSTONE OF U.S. TUNGSTEN SUPPLY, DIRECTLY SUPPORTING NATIONAL EFFORTS TO RESHORE MINED PRODUCTION.
PLC
• Nov. 3, 2025
MEDIA RELATIONS: SAM CONNATTY TEL.: +44 (0)370 904 3601 [email protected]
CGEMY
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST QUANEX BUILDING PRODUCTS CORPORATION ("QUANEX" OR "THE COMPANY") (NYSE: NX) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN DECEMBER 12, 2024 AND SEPTEMBER 5, 2025, INCLUSIVE (THE "CLASS PERIOD"), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE NOVEMBER 18, 2025.
NX
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST QUANEX BUILDING PRODUCTS CORPORATION ("QUANEX " OR "THE COMPANY") (NYSE: NX ) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. SHAREHOLDERS WHO PURCHASED SHARES OF NX DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENTS.
NX
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST MAREX GROUP PLC ("MAREX" OR "THE COMPANY") (NASDAQ: MRX ) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. SHAREHOLDERS WHO PURCHASED SHARES OF MRX DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENTS.
MRX
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST MAREX GROUP PLC ("MAREX" OR "THE COMPANY") (NASDAQ: MRX) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN MAY 16, 2024 AND AUGUST 5, 2025, INCLUSIVE (THE "CLASS PERIOD"), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE DECEMBER 8, 2025.
MRX
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST WPP PLC ("WPP" OR "THE COMPANY") (NYSE: WPP) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN FEBRUARY 27, 2025 AND JULY 8, 2025, INCLUSIVE (THE "CLASS PERIOD"), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE DECEMBER 8, 2025.
WPP
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST BAXTER INTERNATIONAL INC. ("BAXTER" OR "THE COMPANY") (NYSE: BAX) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN MAY 25, 2022 AND FEBRUARY 8, 2023, INCLUSIVE (THE ''CLASS PERIOD''), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE SEPTEMBER 11, 2023.
BAX
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST ATYR PHARMA, INC. ("ATYR" OR "THE COMPANY") (NASDAQ: ATYR) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN JANUARY 16, 2025 AND SEPTEMBER 12, 2025, INCLUSIVE (THE "CLASS PERIOD"), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE DECEMBER 8, 2025.
ATYR
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST KBR, INC. (" KBR" OR "THE COMPANY") (NYSE: KBR ) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. SHAREHOLDERS WHO PURCHASED SHARES OF KBR DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENTS.
KBR
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST KBR, INC. ("KBR" OR "THE COMPANY") (NYSE: KBR) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN MAY 6, 2025 AND JUNE 19, 2025, INCLUSIVE (THE "CLASS PERIOD"), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE NOVEMBER 18, 2025.
KBR
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST CYTOKINETICS, INCORPORATED ("CYTOKINETICS " OR "THE COMPANY") (NASDAQ: CYTK ) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. SHAREHOLDERS WHO PURCHASED SHARES OF CYTK DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENTS.
CYTK
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST V.F. CORPORATION ("VF" OR "THE COMPANY") (NYSE: VFC) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION.
VFC
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST LANTHEUS HOLDINGS, INC. ("LANTHEUS" OR "THE COMPANY") (NASDAQ: LNTH) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN FEBRUARY 26, 2025, AND AUGUST 5, 2025, INCLUSIVE (THE "CLASS PERIOD"), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE NOVEMBER 10, 2025.
LNTH
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE SCHALL LAW FIRM , A NATIONAL SHAREHOLDER RIGHTS LITIGATION FIRM, REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST FLY-E GROUP, INC. ("FLY-E" OR "THE COMPANY") (NASDAQ: FLYE) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. INVESTORS WHO PURCHASED THE COMPANY'S SECURITIES BETWEEN JULY 15, 2025, AND AUGUST 14, 2025, INCLUSIVE (THE "CLASS PERIOD"), ARE ENCOURAGED TO CONTACT THE FIRM BEFORE NOVEMBER 7, 2025.
FLYE
• Nov. 3, 2025
LOS ANGELES , NOV. 3, 2025 /PRNEWSWIRE/ -- THE DJS LAW GROUP REMINDS INVESTORS OF A CLASS ACTION LAWSUIT AGAINST TRONOX HOLDINGS PLC ("TRONOX" OR "THE COMPANY") (NYSE: TROX ) FOR VIOLATIONS OF §§10(B) AND 20(A) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 10B-5 PROMULGATED THEREUNDER BY THE U.S. SECURITIES AND EXCHANGE COMMISSION. SHAREHOLDERS WHO PURCHASED SHARES OF TROX DURING THE CLASS PERIOD LISTED ARE ENCOURAGED TO CONTACT THE FIRM REGARDING POSSIBLE LEAD PLAINTIFF APPOINTMENTS.
TROX
• Nov. 3, 2025
MR. MICHAEL X. SCHLUMPBERGER APPOINTMENT TO THE BOARD LONDON, GB / ACCESS NEWSWIRE / NOVEMBER 3, 2025 / GUARDIAN METAL RESOURCES PLC (LON:GMET)(OTCQB:GMTLF), A STRATEGIC MINERAL EXPLORATION AND DEVELOPMENT COMPANY FOCUSED ON TUNGSTEN IN NEVADA, U.S., IS PLEASED TO ANNOUNCE THAT MR.
GMTLF
• Nov. 3, 2025
DALLAS--(BUSINESS WIRE)--KOSMOS ENERGY LTD. (“KOSMOS” OR THE “COMPANY”) (NYSE/LSE: KOS) ANNOUNCED TODAY ITS FINANCIAL AND OPERATING RESULTS FOR THE THIRD QUARTER OF 2025. FOR THE QUARTER, THE COMPANY GENERATED A NET LOSS OF $124 MILLION, OR $0.26 PER DILUTED SHARE. WHEN ADJUSTED FOR CERTAIN ITEMS THAT IMPACT THE COMPARABILITY OF RESULTS, THE COMPANY GENERATED AN ADJUSTED NET LOSS(1) OF $72 MILLION, OR $0.15 PER DILUTED SHARE FOR THE THIRD QUARTER OF 2025. THIRD QUARTER 2025 HIGHLIGHTS NET PRODU.
KOS
• Nov. 3, 2025
OSLO, 3 NOVEMBER 2025: SCATEC ASA ("SCATEC") HAS MANDATED ARCTIC SECURITIES, DNB CARNEGIE, NORDEA AND SB1 MARKETS TO ARRANGE A SERIES OF FIXED INCOME INVESTOR MEETINGS COMMENCING TUESDAY, 4 NOVEMBER 2025. A NOK 1,250 MILLION (EXPECTED) SENIOR UNSECURED GREEN BOND ISSUE WITH A 4.25-YEAR MATURITY MAY FOLLOW, SUBJECT TO INTER ALIA MARKET CONDITIONS.
ASA
• Nov. 3, 2025
REYKJAVÍK, NOV. 03, 2025 (GLOBE NEWSWIRE) -- AMAROQ LTD. (“AMAROQ” OR THE “COMPANY”) NOTICE TO HOLDERS OF ICELANDIC DEPOSITORY RECEIPTS CONFIRMATION OF EFFECTIVE DATE FOR CONVERSION OF ICELANDIC DEPOSITORY RECEIPTS (IDRS) INTO DEPOSITARY INTERESTS (DIS) TORONTO, ONTARIO – 03 NOVEMBER 2025 – AMAROQ LTD.
AMRQF
• Nov. 3, 2025
AUSTIN, NOV. 03, 2025 (GLOBE NEWSWIRE) -- MILLIMETER WAVE TECHNOLOGY MARKET SIZE AND GROWTH INSIGHTS: ACCORDING TO THE SNS INSIDER,"THE MILLIMETER WAVE TECHNOLOGY MARKET SIZE WAS VALUED AT USD 3. 19 BILLION IN 2024 AND IS EXPECTED TO REACH USD 29.
• Nov. 3, 2025
SCHIPHOL, NOVEMBER 3, 2025 - AEGON ANNOUNCES TODAY THAT DAVID HERZOG, WHO WAS APPOINTED AS A MEMBER OF THE BOARD OF DIRECTORS (BOD) AT AEGON'S 2025 ANNUAL GENERAL MEETING OF SHAREHOLDERS (AGM), WILL SUCCEED WILLIAM CONNELLY AS CHAIRMAN OF THE BOD AS OF NOVEMBER 13, 2025. IN LINE WITH PREVIOUS ANNOUNCEMENTS, MR CONNELLY WILL RETIRE AS CHAIRMAN AND MEMBER OF THE BOD ON THE SAME DATE.
AEG
• Nov. 3, 2025
MILAN--(BUSINESS WIRE)--AN ACCENTURE STUDY FINDS THAT EUROPE IS SEEKING GREATER AI SOVEREIGNTY.
ACN
• Nov. 3, 2025
NEW YORK, NOV. 03, 2025 (GLOBE NEWSWIRE) -- BERNSTEIN LIEBHARD LLP, A NATIONALLY ACCLAIMED INVESTOR RIGHTS LAW FIRM, REMINDS BAXTER INTERNATIONAL INC. (“BAXTER” OR THE “COMPANY”) (NYSE: BAX) INVESTORS OF AN UPCOMING DEADLINE INVOLVING A SECURITIES FRAUD CLASS ACTION LAWSUIT COMMENCED AGAINST THE COMPANY. SHOULD YOU JOIN THIS CLASS ACTION LAWSUIT?
BAX
• Nov. 3, 2025
NEW YORK, NOV. 03, 2025 (GLOBE NEWSWIRE) -- BERNSTEIN LIEBHARD LLP, A NATIONALLY ACCLAIMED INVESTOR RIGHTS LAW FIRM, REMINDS WPP PLC (“WPP” OR THE “COMPANY”) (NYSE: WPP) INVESTORS OF AN UPCOMING DEADLINE INVOLVING A SECURITIES FRAUD CLASS ACTION LAWSUIT COMMENCED AGAINST THE COMPANY. SHOULD YOU JOIN THIS CLASS ACTION LAWSUIT?
WPP
• Nov. 3, 2025
NEW YORK, NOV. 03, 2025 (GLOBE NEWSWIRE) -- BERNSTEIN LIEBHARD LLP, A NATIONALLY ACCLAIMED INVESTOR RIGHTS LAW FIRM, REMINDS JAMES HARDIE INDUSTRIES PLC (“JAMES HARDIE” OR THE “COMPANY”) (NYSE: JHX) INVESTORS OF AN UPCOMING DEADLINE INVOLVING A SECURITIES FRAUD CLASS ACTION LAWSUIT COMMENCED AGAINST THE COMPANY. SHOULD YOU JOIN THIS CLASS ACTION LAWSUIT?
JHX
• Nov. 3, 2025
NEW YORK, NOV. 03, 2025 (GLOBE NEWSWIRE) -- BERNSTEIN LIEBHARD LLP, A NATIONALLY ACCLAIMED INVESTOR RIGHTS LAW FIRM, REMINDS FLY-E GROUP, INC. (“FLY-E” OR THE “COMPANY”) (NASDAQ: FLYE) INVESTORS OF AN UPCOMING DEADLINE INVOLVING A SECURITIES FRAUD CLASS ACTION LAWSUIT COMMENCED AGAINST THE COMPANY. SHOULD YOU JOIN THIS CLASS ACTION LAWSUIT?
FLYE
• Nov. 3, 2025
NEW YORK, NOV. 03, 2025 (GLOBE NEWSWIRE) -- BERNSTEIN LIEBHARD LLP, A NATIONALLY ACCLAIMED INVESTOR RIGHTS LAW FIRM, REMINDS AVANTOR, INC. (“AVANTOR” OR THE “COMPANY”) (NYSE: AVTR) INVESTORS OF AN UPCOMING DEADLINE INVOLVING A SECURITIES FRAUD CLASS ACTION LAWSUIT COMMENCED AGAINST THE COMPANY. SHOULD YOU JOIN THIS CLASS ACTION LAWSUIT?
AVTR
• Nov. 3, 2025
NEW YORK, NOV. 03, 2025 (GLOBE NEWSWIRE) -- BERNSTEIN LIEBHARD LLP, A NATIONALLY ACCLAIMED INVESTOR RIGHTS LAW FIRM, REMINDS MOONLAKE IMMUNOTHERAPEUTICS (“MOONLAKE” OR THE “COMPANY”) (NASDAQ: MLTX) INVESTORS OF AN UPCOMING DEADLINE INVOLVING A SECURITIES FRAUD CLASS ACTION LAWSUIT COMMENCED AGAINST THE COMPANY. SHOULD YOU JOIN THIS CLASS ACTION LAWSUIT?
MLTX
• Nov. 3, 2025
NEW YORK, NOV. 03, 2025 (GLOBE NEWSWIRE) -- BERNSTEIN LIEBHARD LLP, A NATIONALLY ACCLAIMED INVESTOR RIGHTS LAW FIRM, REMINDS LANTHEUS HOLDINGS, INC. (“LANTHEUS” OR THE “COMPANY”) (NASDAQ: LNTH) INVESTORS OF AN UPCOMING DEADLINE INVOLVING A SECURITIES FRAUD CLASS ACTION LAWSUIT COMMENCED AGAINST THE COMPANY. SHOULD YOU JOIN THIS CLASS ACTION LAWSUIT?
LNTH
• Nov. 3, 2025
NEW YORK, NOV. 03, 2025 (GLOBE NEWSWIRE) -- BERNSTEIN LIEBHARD LLP, A NATIONALLY ACCLAIMED INVESTOR RIGHTS LAW FIRM, REMINDS FLUOR CORPORATION (“FLUOR” OR THE “COMPANY”) (NYSE: FLR) INVESTORS OF AN UPCOMING DEADLINE INVOLVING A SECURITIES FRAUD CLASS ACTION LAWSUIT COMMENCED AGAINST THE COMPANY. SHOULD YOU JOIN THIS CLASS ACTION LAWSUIT?
FLR
• Nov. 3, 2025
NEW YORK, NOV. 03, 2025 (GLOBE NEWSWIRE) -- BERNSTEIN LIEBHARD LLP, A NATIONALLY ACCLAIMED INVESTOR RIGHTS LAW FIRM, REMINDS V.F. CORPORATION (“VFC” OR THE “COMPANY”) (NYSE: VFC) INVESTORS OF AN UPCOMING DEADLINE INVOLVING A SECURITIES FRAUD CLASS ACTION LAWSUIT COMMENCED AGAINST THE COMPANY.
VFC
• Nov. 3, 2025
SAN DIEGO , NOV. 3, 2025 /PRNEWSWIRE/ -- THE LAW FIRM OF ROBBINS GELLER RUDMAN & DOWD LLP ANNOUNCES THAT PURCHASERS OR ACQUIRERS OF MOLINA HEALTHCARE, INC. (NYSE: MOH) SECURITIES BETWEEN FEBRUARY 5, 2025 AND JULY 23, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), HAVE UNTIL TUESDAY, DECEMBER 2, 2025 TO SEEK APPOINTMENT AS LEAD PLAINTIFF OF THE MOLINA CLASS ACTION LAWSUIT. CAPTIONED HINDLEMANN V.
MOH
• Nov. 3, 2025
SOUTH SAN FRANCISCO, CALIF.--(BUSINESS WIRE)--GENENTECH, A MEMBER OF THE ROCHE GROUP (SIX: RO, ROG; OTCQX: RHHBY), ANNOUNCED TODAY STATISTICALLY SIGNIFICANT AND CLINICALLY MEANINGFUL RESULTS FROM THE PHASE III ALLEGORY STUDY OF GAZYVA® (OBINUTUZUMAB) IN ADULTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) ON STANDARD THERAPY. THE STUDY MET ITS PRIMARY ENDPOINT SHOWING A HIGHER PERCENTAGE OF PEOPLE ACHIEVED A MINIMUM FOUR-POINT IMPROVEMENT IN SLE RESPONDER INDEX 4 (SRI-4) AT ONE YEAR (52 WEEKS) WITH G.
RHHBY
• Nov. 3, 2025
BASEL, 3 NOVEMBER 2025 - ROCHE (SIX: RO, ROG; OTCQX: RHHBY) ANNOUNCED TODAY STATISTICALLY SIGNIFICANT AND CLINICALLY MEANINGFUL RESULTS FROM THE PHASE III ALLEGORY STUDY OF GAZYVA®/GAZYVARO® (OBINUTUZUMAB) IN ADULTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) ON STANDARD THERAPY. THE STUDY MET ITS PRIMARY ENDPOINT SHOWING A HIGHER PERCENTAGE OF PEOPLE ACHIEVED A MINIMUM FOUR-POINT IMPROVEMENT IN SLE RESPONDER INDEX 4 (SRI-4) AT ONE YEAR (52 WEEKS) WITH GAZYVA/GAZYVARO VERSUS STANDARD THERAPY.2 SRI IS A TOOL THAT ASSESSES CHANGES IN DISEASE SEVERITY, SYMPTOMS AND PHYSICAL CONDITION TO INDICATE WHETHER TREATMENT IS EFFECTIVE AT CONTROLLING DISEASE ACTIVITY. ALL KEY SECONDARY ENDPOINTS WERE ALSO MET. NO NEW SAFETY SIGNALS WERE IDENTIFIED, AND SAFETY WAS IN LINE WITH THE WELL-CHARACTERISED PROFILE OF GAZYVA/GAZYVARO.
RHHBY
• Nov. 3, 2025
ZURICH-SCHLIEREN, SWITZERLAND AND CONCORD, MASS., NOV. 03, 2025 (GLOBE NEWSWIRE) -- AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR MOLECULAR PARTNERS AG (SIX: MOLN; NASDAQ: MOLN), A CLINICAL-STAGE BIOTECH COMPANY DEVELOPING A NEW CLASS OF CUSTOM-BUILT PROTEIN DRUGS KNOWN AS DARPIN THERAPEUTICS (“MOLECULAR PARTNERS” OR THE “COMPANY”), TODAY ANNOUNCED IT WILL PRESENT FURTHER PRECLINICAL PROOF-OF-CONCEPT DATA ON ITS LOGIC-GATED CD3 SWITCH-DARPIN T CELL ENGAGER (TCE) WITH CD2 CO-STIMULATION IN A POSTER AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 2025 MEETING, TAKING PLACE IN NATIONAL HARBOR, MD, USA FROM NOVEMBER 5-9.
MOLN
• Nov. 3, 2025
ZURICH-SCHLIEREN, SWITZERLAND AND CONCORD, MASS., NOV. 03, 2025 (GLOBE NEWSWIRE) -- AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR MOLECULAR PARTNERS AG (SIX: MOLN; NASDAQ: MOLN), A CLINICAL-STAGE BIOTECH COMPANY DEVELOPING A NEW CLASS OF CUSTOM-BUILT PROTEIN DRUGS KNOWN AS DARPIN THERAPEUTICS (“MOLECULAR PARTNERS” OR THE “COMPANY”), TODAY ANNOUNCED IT WILL PRESENT UPDATED DATA FROM A PHASE 1/2A TRIAL OF MP0533, A NOVEL, MULTISPECIFIC T CELL ENGAGER FOR ACUTE MYELOID LEUKEMIA (AML) PATIENTS, IN A POSTER AT THE 67TH AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING AND EXPOSITION, TAKING PLACE DECEMBER 6-9, 2025, IN ORLANDO, FLORIDA, AND ONLINE.
PGPHF
• Nov. 3, 2025
SAN ANTONIO, TEXAS--(NEWSFILE CORP. - NOVEMBER 3, 2025) - HIVE DIGITAL TECHNOLOGIES LTD. (TSXV: HIVE) (NASDAQ: HIVE) (FSE: YO0) (THE "COMPANY" OR "HIVE"), A GLOBAL LEADER IN SUSTAINABLE DIGITAL INFRASTRUCTURE, TODAY ANNOUNCED A PIVOTAL MILESTONE IN THE HEART OF THE AI SUPER CYCLE: ACHIEVING 23 EXAHASH PER SECOND ("EH/S") IN GLOBAL BITCOIN-MINING CAPACITY-POSITIONING THE COMPANY AMONGST INDUSTRY LEADERS IN 2025 WITH 283% YEAR-TO-DATE GROWTH (ALL AMOUNTS IN US DOLLARS, UNLESS OTHERWISE INDICATED).
HIVE
• Nov. 3, 2025
- EARNINGS CALL SCHEDULED FOR 7:00 A.M. ET ON NOVEMBER 14 , 2025 - SHENZHEN, CHINA , NOV. 3, 2025 /PRNEWSWIRE/ -- RLX TECHNOLOGY INC. ("RLX TECHNOLOGY" OR THE "COMPANY") (NYSE: RLX), A LEADING GLOBAL BRANDED E-VAPOR COMPANY, TODAY ANNOUNCED THAT IT WILL REPORT ITS UNAUDITED FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025, BEFORE THE U.S. MARKETS OPEN ON FRIDAY, NOVEMBER 14, 2025.
RLX
• Nov. 3, 2025
SHANGHAI--(BUSINESS WIRE)--FROM OCTOBER 26, CHINA EASTERN AIRLINES (CEA) OFFICIALLY IMPLEMENTED ITS 2025 WINTER-SPRING FLIGHT SCHEDULE. IN THIS NEW SEASON, THE AIRLINE WILL OPERATE WITH 820 AIRCRAFT, COVERING 39 COUNTRIES AND 253 DOMESTIC AND INTERNATIONAL DESTINATIONS, INCLUDING 88 OVERSEAS DESTINATIONS. IT WILL RUN ABOUT 3,130 FLIGHTS PER DAY, WITH AN AVERAGE OF 3,220 INTERNATIONAL AND REGIONAL FLIGHTS PER WEEK. AS THIS SEASON ALIGNS WITH THE SOUTHERN HEMISPHERE'S MIDSUMMER, NEW ZEALAND, AUST.
CHEAF
• Nov. 3, 2025
HOUSTON--(BUSINESS WIRE)--DNOW ANNOUNCES THIRD QUARTER 2025 EARNINGS CONFERENCE CALL.
DNOW
• Nov. 3, 2025
JOINT DEVELOPMENT AGREEMENT WILL ESTABLISH A FOUNDATION FOR ULTRA-HIGH ENERGY DENSITY MICROBATTERIES SAN JOSE, CALIFORNIA, UNITED STATES - ENSURGE (OSE: ENSU), A GLOBAL LEADER IN SOLID-STATE MICROBATTERY TECHNOLOGY, AND CORNING INCORPORATED (NYSE: GLW), ONE OF THE WORLD'S LEADING INNOVATORS IN GLASS, CERAMICS, AND MATERIALS SCIENCE, TODAY ANNOUNCED A SET OF AGREEMENTS TO JOINTLY DEVELOP ENSURGE'S ULTRA-HIGH PERFORMANCE SOLID-STATE MICROBATTERIES. THE AGREEMENTS ESTABLISH A FRAMEWORK FOR THE TWO COMPANIES TO INTEGRATE CORNING'S RIBBON CERAMIC MATERIALS AND PROCESS TECHNOLOGY WITH ENSURGE'S PROVEN SOLID-STATE MICROBATTERY ARCHITECTURE.
ENMPY
• Nov. 3, 2025
OSLO, NORWAY, 3 NOVEMBER 2025 ENSURGE MICROPOWER ASA ("ENSURGE" OR THE "COMPANY") TODAY ANNOUNCES THAT THE COMPANY HAS ENTERED INTO A SET OF AGREEMENTS WITH CORNING INCORPORATED (“CORNING”), ONE OF THE WORLD'S LEADING INNOVATORS IN GLASS, CERAMICS, AND MATERIALS SCIENCE, TO JOINTLY DEVELOP ULTRA-HIGH PERFORMANCE SOLID-STATE MICROBATTERIES BASED ON ENSURGE'S PLATFORM.
ASA
• Nov. 3, 2025
HOUSTON--(BUSINESS WIRE)--SABLE OFFSHORE CORP. TO HOST CONFERENCE CALL TO PROVIDE A STRATEGIC UPDATE TO INVESTORS.
SOC
• Nov. 2, 2025
VANCOUVER, BC / ACCESS NEWSWIRE / NOVEMBER 2, 2025 / LINEAR MINERALS CORP. (CSE:LINE)(OTC:LINMF)(WKN:A2J C89) ("LINEAR" OR THE "COMPANY") IS PLEASED TO ANNOUNCE THE RESULTS OF ITS INITIAL EXPLORATION PROGRAM AT THE LAC MARION URANIUM AND RARE EARTH ELEMENT (REE) PROPERTY (THE "PROPERTY"), LOCATED NEAR MONT LAURIER IN THE LAURENTIDES REGION OF SOUTHWESTERN QUÉBEC. THE PROGRAM INCLUDED GEOLOGICAL MAPPING, PROSPECTING, RADIOMETRIC SURVEYS, AND ROCK SAMPLING ACROSS THE 2,760-HECTARE LAND PACKAGE.
MTX
• Nov. 2, 2025
HONG KONG , NOV. 2, 2025 /PRNEWSWIRE/ -- AKESO (9926.HK) ANNOUNCED THAT ITS FIRST-IN-CLASS BISPECIFIC ANTIBODY, IVONESCIMAB (PD-1/VEGF BISPECIFIC ANTIBODY), IN COMBINATION WITH CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF TRIPLE-NEGATIVE BREAST CANCER (TNBC) HAS BEEN GRANTED BREAKTHROUGH THERAPY DESIGNATION (BTD) BY THE CENTER FOR DRUG EVALUATION (CDE) FROM CHINA'S NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA). THE PHASE III MULTICENTER, RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL (HARMONI-BC1/AK112-308) FOR THIS COMBINATION THERAPY IS ONGOING IN CHINA.
AKESF
• Nov. 2, 2025
NEW YORK , NOV. 2, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF SECURITIES OF V.F. CORPORATION (NYSE: VFC) BETWEEN OCTOBER 30, 2023 AND MAY 20, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT NOVEMBER 12, 2025 LEAD PLAINTIFF DEADLINE.
VFC
• Nov. 2, 2025
NEW YORK , NOV. 2, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF SECURITIES OF SAVARA INC. (NASDAQ: SVRA) BETWEEN MARCH 7, 2024 AND MAY 23, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT NOVEMBER 7, 2025 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED SAVARA SECURITIES DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
SVRA
• Nov. 2, 2025
LOS ANGELES, NOV. 02, 2025 (GLOBE NEWSWIRE) -- FARADAY FUTURE INTELLIGENT ELECTRIC INC. (NASDAQ: FFAI) (“FARADAY FUTURE,” “FF” OR THE “COMPANY”), A CALIFORNIA-BASED GLOBAL SHARED INTELLIGENT ELECTRIC MOBILITY ECOSYSTEM COMPANY, TODAY ANNOUNCED A GLOBAL STRATEGIC ADVISORY AGREEMENT WITH CHRIS NIXON COX, BOARD MEMBER OF THE RICHARD NIXON FOUNDATION AND GRANDSON OF THE 37TH PRESIDENT OF THE UNITED STATES, RICHARD NIXON. MR. COX WILL SERVE AS A SENIOR ADVISOR FOR GLOBAL INVESTOR RELATIONS, GOVERNMENT AFFAIRS, AND INDUSTRIAL COOPERATION, SUPPORTING THE ACCELERATED INTERNATIONAL DEPLOYMENT OF FF'S “EAI + CRYPTO” DUAL-FLYWHEEL AND DUAL-BRIDGE STRATEGY.
FFAI
• Nov. 2, 2025
INCHEON, KOREA--(BUSINESS WIRE)-- #SAMSUNGBIOEPIS--SAMSUNG EPIS HOLDINGS ANNOUNCED ITS ESTABLISHMENT AS AN INVESTMENT HOLDING COMPANY, FOLLOWING THE SPIN-OFF OF SAMSUNG BIOEPIS FROM SAMSUNG BIOLOGICS.
SSNLF
• Nov. 2, 2025
NEW YORK, NOV. 02, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF COMMON STOCK OF TRONOX HOLDINGS PLC (NYSE: TROX) BETWEEN FEBRUARY 12, 2025 AND JULY 30, 2025, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”), OF THE IMPORTANT NOVEMBER 3, 2025 LEAD PLAINTIFF DEADLINE.
TROX
• Nov. 2, 2025
NEW YORK, NOV. 02, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, CONTINUES TO INVESTIGATE POTENTIAL SECURITIES CLAIMS ON BEHALF OF SHAREHOLDERS OF TELIX PHARMACEUTICALS LTD. (NASDAQ: TLX) RESULTING FROM ALLEGATIONS THAT TELIX MAY HAVE ISSUED MATERIALLY MISLEADING BUSINESS INFORMATION TO THE INVESTING PUBLIC.
TLX
• Nov. 2, 2025
SINGAPORE--(BUSINESS WIRE)-- #ASSETMANAGEMENT--NORTHERN TRUST WILL PROVIDE FUND ADMINISTRATION AND OTHER SERVICES, BUILDING ON A RELATIONSHIP WITH AVANDA THAT BEGAN IN 2015.
NTRS
• Nov. 2, 2025
— HUTCHMED UNVEILS ITS INNOVATIVE ATTC PLATFORM, POTENTIALLY PROVIDING PRECISION ONCOLOGY WITH SYNERGISTIC DUAL-MECHANISM OF ACTION —
HCM
• Nov. 2, 2025
INVESTOR WEBCAST TO BE HELD ON MONDAY NOVEMBER 3, 2025 AT 8:00 AM EST INVESTOR WEBCAST TO BE HELD ON MONDAY NOVEMBER 3, 2025 AT 8:00 AM EST
BNTC
• Nov. 2, 2025
NEW YORK, NOV. 02, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF AMERICAN DEPOSITARY SHARES (“ADS” OR “ADSS”) OF WPP PLC (NYSE: WPP) BETWEEN FEBRUARY 27, 2025 AND JULY 8, 2025, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”), OF THE IMPORTANT DECEMBER 8, 2025 LEAD PLAINTIFF DEADLINE.
WPP
• Nov. 2, 2025
NEW YORK, NOV. 02, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF SECURITIES OF SAVARA INC. (NASDAQ: SVRA) BETWEEN MARCH 7, 2024 AND MAY 23, 2025, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”), OF THE IMPORTANT NOVEMBER 7, 2025 LEAD PLAINTIFF DEADLINE.
SVRA
• Nov. 2, 2025
NEW YORK, NOV. 02, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF SECURITIES OF LANTHEUS HOLDINGS, INC. (NASDAQ: LNTH) BETWEEN FEBRUARY 26, 2025 AND AUGUST 5, 2025, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”), OF THE IMPORTANT NOVEMBER 10, 2025 LEAD PLAINTIFF DEADLINE.
LNTH
• Nov. 2, 2025
REYKJAVIK, ICELAND, NOV. 02, 2025 (GLOBE NEWSWIRE) -- ALVOTECH (NASDAQ: ALVO), A GLOBAL BIOTECH COMPANY SPECIALIZING IN THE DEVELOPMENT AND MANUFACTURE OF BIOSIMILAR MEDICINES FOR PATIENTS WORLDWIDE, ANNOUNCED TODAY THAT THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) HAS ISSUED A COMPLETE RESPONSE LETTER (CRL) FOR ALVOTECH'S BIOLOGICS LICENSE APPLICATION (BLA) FOR AVT05, IN A PREFILLED SYRINGE AND AUTOINJECTOR PRESENTATIONS, A BIOSIMILAR CANDIDATE TO SIMPONI® (GOLIMUMAB).
ALVO
• Nov. 2, 2025
NEW YORK, NOV. 02, 2025 (GLOBE NEWSWIRE) -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, ANNOUNCES THE FILING OF A CLASS ACTION LAWSUIT ON BEHALF OF PURCHASERS OF COMMON STOCK OF AVANTOR, INC. (NYSE: AVTR) BETWEEN MARCH 5, 2024 AND OCTOBER 28, 2025, BOTH DATES INCLUSIVE (THE “CLASS PERIOD”). A CLASS ACTION LAWSUIT HAS ALREADY BEEN FILED. IF YOU WISH TO SERVE AS LEAD PLAINTIFF, YOU MUST MOVE THE COURT NO LATER THAN DECEMBER 29, 2025.
AVTR
• Nov. 2, 2025
BERKELEY, CALIF., NOV. 02, 2025 (GLOBE NEWSWIRE) -- CARIBOU BIOSCIENCES, INC. (NASDAQ: CRBU), A LEADING CLINICAL-STAGE CRISPR GENOME-EDITING BIOPHARMACEUTICAL COMPANY, TODAY ANNOUNCED THAT IT WILL HOLD A WEBCAST BEGINNING AT 8:00 AM ET ON MONDAY, NOVEMBER 3, 2025, TO REPORT NEW DATA FROM THE ANTLER PHASE 1 CLINICAL TRIAL EVALUATING VISPACABTAGENE REGEDLEUCEL (VISPA-CEL; FORMERLY CB-010), AN ALLOGENEIC ANTI-CD19 CAR-T CELL THERAPY, IN PATIENTS WITH RELAPSED OR REFRACTORY B CELL NON-HODGKIN LYMPHOMA (R/R B-NHL) AND REPORT THE FIRST CLINICAL DATA FROM THE CAMMOUFLAGE PHASE 1 CLINICAL TRIAL EVALUATING CB-011, AN ALLOGENEIC ANTI-BCMA CAR-T CELL THERAPY, IN PATIENTS WITH R/R MULTIPLE MYELOMA. THE COMPANY WILL ALSO REPORT ITS ANTICIPATED PIVOTAL PHASE 3 TRIAL DESIGN FOR VISPA-CEL AND NEXT STEPS FOR THE CONTINUED CLINICAL DEVELOPMENT OF CB-011.
CAR
• Nov. 2, 2025
